<DOC>
	<DOCNO>NCT00855387</DOCNO>
	<brief_summary>The purpose study prospectively assess impact surgical quality overall cost major surgical procedure use incidence severity complication surrogate marker quality .</brief_summary>
	<brief_title>Severe Complications Triplicate Costs Major Surgical Procedures</brief_title>
	<detailed_description>To prospectively assess impact surgical quality overall cost major surgical procedure use incidence severity complication surrogate marker quality</detailed_description>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Undergoing major surgery ( liver , bile duct , pancreas , colorectal , gastric bypass small bowel resection ) Missing data inhospital cost Mortality</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Clinical outcome ( complication ) , in-hospital cost</keyword>
	<keyword>The influence impact postoperative complication in-hospital cost</keyword>
</DOC>